Low-Dose Pioglitazone does not Increase ROS Production in Chronic Granulomatous Disease Patients with Severe Infection

Xiaoying Hui,Danru Liu,Wenjie Wang,Jia Hou,Wenjing Ying,Qinhua Zhou,Haili Yao,Jinqiao Sun,Xiaochuan Wang

Low-Dose Pioglitazone does not Increase ROS Production in Chronic Granulomatous Disease Patients with Severe Infection

2019

Xiaoying Hui
Danru Liu
Wenjie Wang
Jia Hou
Wenjing Ying
Qinhua Zhou
Haili Yao
Jinqiao Sun
Xiaochuan Wang

Purpose We sought to further investigate the efficacy and safety of pioglitazone for chronic granulomatous disease (CGD) patients with severe infection.

Keywords:

Biology
Immunology
CYBB
Pioglitazone
Chronic granulomatous disease
Lymph node
Gastroenterology
Lung
Medical microbiology
Age of onset
Adverse effect
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations